Medicaid Coverage for Medication-Assisted Treatment of Alcohol and Opioid Use Disorder
$13.50 | CE Hours:4.50 | Intermediate
CE Course Description
Given the important role that medication can play in treating substance use disorders (SUDs), it is critical that Medicaid programs develop clinically effective and cost-effective delivery and financing approaches to providing these medications to beneficiaries. This CE course presents information about Medicaid coverage of medications used to treat alcohol and opioid use disorders.
Author: Substance Abuse and Mental Health Services Administration. Medicaid Coverage of Medication-Assisted Treatment for Alcohol and Opioid Use Disorders and of Medication for the Reversal of Opioid Overdose. (2018, November). HHS Publication No. SMA-18-5093. Rockville, MD: Substance Abuse and Mental Health Services Administration.
Retrieved from: https://store.samhsa.gov/product/SMA18-5093
CE Course Objectives
1. Conclude the most frequently reported reason for not receiving treatment among individuals who recognized a need for treatment and tried to obtain it.
2. Evaluate which phase of treatment buprenorphine combined with naloxone can be used for.
3. Identify an effective medication used to reverse opioid overdose.
4. List three factors that scientific research has found are helped by medications for alcohol use disorders.
5. Name the most effective medication at reducing the cost for alcoholism-related inpatient hospitalizations and detoxification among individuals treated with MAT.
6. Provide one characteristic that plays a significant role in the effectiveness of naltrexone.
CE Outline with Main Points
1. Executive Summary
b. Study Methods
c. Key Findings
3. State Considerations for Covering Medications for Alcohol and Opioid Use Disorders
a. Efficacy of Medications Used to Treat Alcohol and Opioid Use Disorders
b. Cost Offset and Cost Effectiveness of Medications for Alcohol and Opioid Use Disorders
c. State and Federal Regulations and Policies Affecting the Prescription and
d. Dispensing of Medications for Alcohol and Opioid Use Disorders
4. Medicaid Coverage of Medications for Alcohol and Opioid Use Disorders
a. Data Sources and Methodology
b. Medicaid Benefit Limits on Medications for Alcohol and Opioid Use Disorders
5. Innovative MAT Provision, Coverage, and Financing Models
a. Innovative Models
b. Cross-Cutting Best Practices
Quantum Units Education, #1289, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Quantum Units Education maintains responsibility for this course. ACE provider approval period: 01/03/2019 – 01/03/2020. Social workers completing this course receive 4.50 continuing education credits.
Course Development: Each course is identified and reviewed by the appropriate Quantum Units Education consultant with professional and licensed expertise in the various disciplines we serve. Our professional consultants oversee course development to satisfy the needs of various professionals based on their board requirements, rate course degree of difficulty and ensure the course content and exam questions are appropriate, relevant and comprehensive. See our professional staff and their bios here.
*Board Approvals for this course can be found here.
*Questions regarding how to take a course, refunds, grievance policy and ADA policy can be found here.
*Questions regarding this course or need support? Contact us at: firstname.lastname@example.org.
Added On: 2019-02-11